Chapter 1. BCG: its impact on tuberculosis and relevance to autoimmune disease -- Chapter 2. The potential of TNF induction from BCG for the treatment of Type 1 Diabetes -- Chapter 3. Bacille Calmette-Guerin (BCG) vaccine in neuroinflammation -- Chapter 4. Host epigenetic modifications in Mycobacterium tuberculosis infection: a boon or bane -- Chapter 5. Mycobacterium Bovis Bacille Calmette-Guerin vaccination: can biomarkers predict efficacy? -- Chapter 6. The heterologous effects of Bacillus Calmette-Guerin (BCG) vaccine and trained innate immunity -- Chapter 7. Nonspecific effects of neonatal Bacille Calmette-Guerin (BCG) vaccination -- from West African observations to a Danish randomized clinical trial -- Chapter 8. Epigenetic rewiring of monocytes in BCG vaccination -- Chapter 9. Mycobacteria, immunoregulation, and autoimmunity -- Chapter 10. mTORC1 links cellular metabolism and immune functions in Mycobacterium tuberculosis infection and BCG vaccination -- Chapter 11. The role of maternal priming and boosting for the nonspecific effects of BCG vaccine -- Index
Bibliography
Includes bibliographical references and index
Notes
Online resource; title from PDF file page (EBSCO, viewed July 23 2018)
